Dacarbazine

Indication

Metastatic cancer

• Dacarbazine (DTIC) 250 mg/m2/d iv d1-5
• Q3w

References

Middleton, MR et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000; 18:158